Archive for July, 2012

At Chitika, we pride ourselves on a very important quality that sets us aside from the competition: our dedication to building and maintaining strong, meaningful relationships with our publishers. Our customer support is always available to help, whether its by phone, email, or Facebook. We also love to share news with our publishers – from our new products, to our latest office robot. This month marks an occasion that we are particularly proud of, which is 70 months of consecutive on-time payments to our network of publishers.

As you know, publishers are becoming wary of joining new networks because there is uncertainty on whether or not they will actually receive the money that they have earned. After almost 6 years of on time payments, Chitika can proudly say that this is not an issue our publishers ever need to worry about. Our publishers’ trust in us is a priority, and will remain to be.

Is a consistent and reliable payment history something you look for when you join a new network? Let us know in the comments below!

At Chitika, we pride ourselves on a very important quality that sets us aside from the competition: our dedication to building and maintaining strong, meaningful relationships with our publishers. Our customer support is always available to help, whether its by phone, email, or Facebook. We also love to share news with our publishers – from our new products, to our latest office robot. This month marks an occasion that we are particularly proud of, which is 70 months of consecutive on-time payments to our network of publishers.

As you know, publishers are becoming wary of joining new networks because there is uncertainty on whether or not they will actually receive the money that they have earned. After almost 6 years of on time payments, Chitika can proudly say that this is not an issue our publishers ever need to worry about. Our publishers’ trust in us is a priority, and will remain to be.

Is a consistent and reliable payment history something you look for when you join a new network? Let us know in the comments below!

My name is Heather Rutkowski and I believe that Behavioral Targeting should be a key ingredient in the marketing plan of every DR focused advertiser. If you think I’m crazy, I would encourage you to read this blog post.

At Microsoft Advertising, we have one of the best Behavioral Targeting platforms available. We see it as a comprehensive solution for marketers, whether they are looking to reach users at the top or bottom of the purchase funnel. While we believe that it is one of the strongest branding tools for advertisers, for the purposes of this blog, I will be focusing on how BT can drive direct response and consumer action.

The secret behind our market-leading BT solutions is our diverse audience powered and authenticated by the Windows Live ID not to mention data from Bing searches. Those millions of people also happen to buy a lot of expensive goods. In fact, Bing users have the highest buying power index (BPI), as compared to Yahoo, AOL and Google. (Source: comScore, December 2011.)Even better, we expect this audience to grow in the future.

5518.Artdeco 2D00 image 5F00 thumb 5F00 1BF3A594 Making Behavioral Targeting Fashionable for Direct Response Conscious AdvertisersYou may be thinking: “does BT really perform as well as Remessaging?” Or, “wouldn’t a CPA campaign be the most low risk option?” And my favorite quote from “DR” marketers- “I only want to run something that is going to perform and hit my ROI. I would prefer to stick with Remessaging and a standard CPA campaign.”So in other words, you are totally ok with losing a majority of your highly qualified audience to your competition?

Let’s take a closer look….

There is no denying that Remessaging does a great job of converting “shoppers” into “buyers.” But what about all of those other qualified consumers that might not even be aware of an advertiser’s product or service and are shopping elsewhere? I like to think of Remessaging as the fancy mannequin in a department store. Having browsed the latest fashion magazines and seen the looks that are on trend and would suit my personal style, on entering the store, this fancy plastic lady reminds me that the “Art Deco” look that I loved in Vogue is totally IN right now. The mannequin is the department store’s Remessaging ad to me, driving me to purchase the latest trend. But what about every other woman in my demographic that is shopping at the department store across the street – or on the other side of the country and doesn’t have the opportunity to see this fancy mannequin because they are not physically INSIDE of this department store?

1563.fashionbillboard 5F00 thumb 5F00 5AE5262F Making Behavioral Targeting Fashionable for Direct Response Conscious AdvertisersWhat if, when all of those women are outside on the street, they saw digital billboards across the country that showed them the trends and clothes that not only map to the designer brands’ objectives, but also align to the type of person that they are, even if they haven’t heard of the designer before? Personalized for better relevance, scaled to reach a broader audience. A far-fetched example, but that is the type of impact BT can have on an interested audience.

Another favorite quote of mine from DR advertisers is: “I don’t want to pay on a CPM for BT, so I will just run a CPA campaign and get the same users that way at no risk.”Let me break this down. It is true that CPA campaigns will always be a low risk for an advertiser- since the advertiser is only paying for conversions; however, the actual impressions that qualify for a CPA campaign are often not the most valuable. Instead, the most qualified cookies are the people that spend the most time and money online and have attractive demographic characteristics for advertisers. These people are most likely already in a number of Remessaging and BT segments. Because of frequency caps, this highly desirable audience will probably never qualify to see many impressions from CPA campaigns. Running a CPA campaign is like getting a free gift with purchase- most people are not ever going to say no to this free gift- but the quality of the gift is often questionable.

Behavioral Targeting is a great way to connect with shoppers that have never even heard of an advertiser’s brand. Microsoft’s BT solution is quickly setting itself apart from the competition, especially as our data footprint grows. Even the most DR focused advertiser should have an overwhelming reason to test BT on the Microsoft Network. If DR metrics are still getting in the way of an advertiser testing BT, an advertiser is essentially giving away customers to the competition.

Heather Rutkowski – Microsoft Advertising

 Making Behavioral Targeting Fashionable for Direct Response Conscious Advertisers

25.07.2012

Greetings,

 There has been many discussions on the XAML version of the MSA Ads SDK. The top questions are around z-index and focus issues.

 The problem
Let’s start with the easy one. A bug exists today where the ad control won’t relinquish UI focus in Windows build 8400.

The solution
The good news is that this is a platform issues that has been resolved in later builds.

The problem
The SDK content lags behind the rest of the app when I scroll/pan my app fast.

The solution
See last parapgraph.

The problem
The more challenging issues is around z-index.  As some of you may have discovered, the ads controls is always on top. This is not an ominous feature to ensure our ads are always shown, but rather an issue with the WebView control that we use in the SDK. See excerpt from the Dev portal.

 WebView has the characteristic that other UI regions such as controls cannot be rendered on top of the WebView. This is because of how window regions are handled internally, particularly how input events are processed and how the screen draws. If you want to render HTML content and also place other UI elements on top of that HTML content, you should use WebViewBrush as the render area.

 The challenge is that the WebViewBrush does not capture events.

 The solution
Unfortunately there is no eloquent solution, but just a work around (please don’t flame me). Here goes….

When you are rendering your content over the ads SDK, set the visibility of the ad control to collapsed and when the content is remove to visible. That does not play well with layout managers like stack panels so what I have tried was to create a dummy rectangle that is the same size than the ad control. This rectangle is default collapsed. When you need to hide the ad control, you show the placeholder and vice-versa.

Like so

<StackPanel HorizontalAlignment=”Left” Height=”730″ Margin=”10,28,0,0″ VerticalAlignment=”Top” Width=”300″>

            <UI:AdControl x:Name=”myAdcontrol” ApplicationId=”test_client” AdUnitId=”Image_300x250″ HorizontalAlignment=”Left” Height=”250″ VerticalAlignment=”Top” Width=”300″/>

            <Rectangle x:Name=”myDummy” HorizontalAlignment=”Left” Height=”250″ Width=”300″ Visibility=”Collapsed”/>

            <Image x:Name=”Content” HorizontalAlignment=”Left” Height=”250″ Width=”300″ Source=”Assets/SmallLogo.png”/>

</StackPanel>

 And with code behind

 if (myAdcontrol.Visibility == Windows.UI.Xaml.Visibility.Visible)

{

      myAdcontrol.Visibility = Windows.UI.Xaml.Visibility.Collapsed;

      myDummy.Visibility = Windows.UI.Xaml.Visibility.Visible;

}

else

{

     myAdcontrol.Visibility = Windows.UI.Xaml.Visibility.Visible;

     myDummy.Visibility = Windows.UI.Xaml.Visibility.Collapsed;

}

 This seems to work in basic layouts and I am sure will be more complicated in more complex layouts. One of the options we are exploring is to handle this internally and expose a method on the ads control e.g. Suspend() and Resume()  that internally attempts to retain the real estate by using a dummy container or by temporary converting to a webviewbrush. We will unfortunately not get away from requiring the developer to signal when they want to render content over the ads and/or suspend animation because of the scrolling lag etc.

 Happy coding!

 Cheers
-          Ian

 

 Challenges with the XAML version of the Ads SDK

MCR American Pharmaceuticals

Author: Daniel Dean
24.07.2012

About MCR American Pharmaceuticals
MCR American Pharmaceuticals is a specialty pharmaceutical company focused on the marketing and development along with sales and distribution of the highest quality pharmaceuticals.

Practitioners have long trusted our products to meet the needs of their patients. We are committed to upholding our high standards. We are determined to provide you with the most convenient methods of acquiring the highest quality pharmaceuticals to meet your specific needs.

History
MCR American Pharmaceuticals was founded by Jack Reagin in 1991 in Birmingham, Alabama. MCR  American Pharmaceuticals quickly expanded to several states in the Southeast. In 1999 MCR American Pharmaceuticals was purchased by Dave Ambrose and was relocated to Brooksville, Florida. In 2008, MCR American Pharmaceuticals was acquired by Neuro-HiTech. The company‚Äôs products are now marketed throughout the United States and sold directly to the general public as well as medical offices, wholesalers, distributors and your local pharmacy.

Products
MCR American is dedicated to providing individuals with self medication products for in home treatment and prevention of medical conditions and ailments. We offer the following products:

  • Congestinex: Congestinex is a expectorant. It contains 100 mg Guaifenesin. It is good for the common cold, it helps loosen phlegm and thin bronchial secretions to make coughs more productive.
  • Congestinex C: Congestinex C is a Antihistamine and Antitussive combination. It contains 1 mg Chlorpheniramine and 5 mg Dextromethorphan. Congestinex is great for patients that have post nasal drip cough.
  • Congestinex DM: Congestinex DM is a Antitussive and Expectorant combination. It contains 5 mg Dextromethorphan and 100 mg Guaifenesin. Congestinex DM loosens chest congestion and relieves cough.
  • Congestinex PE: Congestinex PE is a Antitussive, Expectorant, and Decongestant combination. It contains 5 mg Dextromethorphan, 100 mg Guaifenesin and 2.5 mg Phenylepherine. Congestinex PE relieves symptoms due to common cold, hay fever or other respiratory allergies.
  • Maxiphen: Maxiphen is a decongestant and expectorant combination. It contains 10 mg Phenylephrine and 400 mg Guaifenesin. Is is great for those patients who have congestion due to the common cold, sinusitis, hay fever, and allergic rhinitis.
  • Maxiphen DM: Maxiphen DM is a decongestant, expectorant, and cough suppressant combination. It contains 10 mg Phenylephrine, 400 mg Guaifenesin and 20 mg Dextromethorphan for that post nasal drip cough.
  • Maxifed: Maxifed is a decongestant and expectorant combination. It contains 60 mg Pseudoephedrine and 400 mg Guaifenesin. It is good for the common cold, sinusitis, hay fever and allergic rhinitis.
  • Maxifed DMX: Maxifed DMX is a decongestant, expectorant, and cough suppressant combination. It contains 60 mg Pseudoephedrine, 400 mg Guaifenesin, and 20 mg Dextromethorphan. Maxifed DMX is great for patients that have post nasal drip cough.
  • Maxifed-G: Maxifed-G is a decongestant and expectorant combination. It contains 40 mg Pseudoephedrine and 400 mg Guaifenesin. It is good for the common cold, sinusitis, hay fever and allergic rhinitis.
  • Maxifed DM: Maxifed DM is a decongestant, expectorant, and cough suppressant combination. It contains 40 mg Pseudoephedrine, 400 mg Guaifenesin and 20 mg Dextromethorphan. Maxifed DMX is great for those patients that have post nasal drip cough.
  • Super-Tuss PE: Arrives in an AM dose and PM dose. Is good for the common cold, sinusitis, hay fever and allergic rhinitis.
  • Super-Tuss PSE: Arrives in an AM dose and PM dose. Is good for the common cold, sinusitis, hay fever and allergic rhinitis.


Contact Us
Mailing address:
MCR American Pharmaceuticals
16255 Aviation Loop
Brooksville, FL 34604

Phone number:
352-754-8587
Our business hours are Monday-Friday 8-5 (Eastern), excluding major holidays.
Fax: 352-754-8507

3248018107635893461 3731478177767438709?l=web pr.blogspot MCR American Pharmaceuticals